TDO2 and ovarian carcinoma: Meanwhile, tryptophan 2,3-dioxygenase (TDO2), the rate-limiting enzyme of the kynurenine pathway, was found to be upregulated in ovarian cancer tissues, which promotes tumor cell proliferation, migration and invasion (113).